Correlation Between Immunitybio and Hepion Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Immunitybio and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunitybio and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunitybio and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Immunitybio and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunitybio with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunitybio and Hepion Pharmaceuticals.

Diversification Opportunities for Immunitybio and Hepion Pharmaceuticals

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Immunitybio and Hepion is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Immunitybio and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Immunitybio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunitybio are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Immunitybio i.e., Immunitybio and Hepion Pharmaceuticals go up and down completely randomly.

Pair Corralation between Immunitybio and Hepion Pharmaceuticals

Given the investment horizon of 90 days Immunitybio is expected to under-perform the Hepion Pharmaceuticals. In addition to that, Immunitybio is 1.64 times more volatile than Hepion Pharmaceuticals. It trades about -0.07 of its total potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.05 per unit of volatility. If you would invest  67.00  in Hepion Pharmaceuticals on August 31, 2024 and sell it today you would lose (3.00) from holding Hepion Pharmaceuticals or give up 4.48% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Immunitybio  vs.  Hepion Pharmaceuticals

 Performance 
       Timeline  
Immunitybio 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Immunitybio are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Immunitybio showed solid returns over the last few months and may actually be approaching a breakup point.
Hepion Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hepion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Hepion Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Immunitybio and Hepion Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Immunitybio and Hepion Pharmaceuticals

The main advantage of trading using opposite Immunitybio and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunitybio position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.
The idea behind Immunitybio and Hepion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Money Managers
Screen money managers from public funds and ETFs managed around the world
Transaction History
View history of all your transactions and understand their impact on performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators